These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24806899)

  • 1. Using bioanalysis for cancer diagnosis and prognosis.
    Markuszewski MJ; Kaliszan R
    Bioanalysis; 2014 Apr; 6(7):907-9. PubMed ID: 24806899
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolomic profiling of neoplastic lesions in mice.
    Lu X; Ji LJ; Chen JL
    Methods Enzymol; 2014; 543():261-73. PubMed ID: 24924137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
    Struck-Lewicka W; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
    Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
    J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry based methods for analysis of nucleosides as antiviral drugs and potential tumor biomarkers.
    Agrofoglio LA; Bezy V; Chaimbault P; Delépée R; Rhourri B; Morin P
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1523-7. PubMed ID: 18066819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of urinary nucleosides. II. Comparison of mass spectrometric methods for the analysis of urinary nucleosides.
    Dudley E; Lemiere F; Van Dongen W; Langridge JI; El-Sharkawi S; Games DE; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2001; 15(18):1701-7. PubMed ID: 11555869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics in urogenital cancer.
    Bujak R; Daghir E; Rybka J; Koslinski P; Markuszewski MJ
    Bioanalysis; 2011 Apr; 3(8):913-23. PubMed ID: 21510764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative analysis in quality control of traditional Chinese medicines.
    Liang XM; Jin Y; Wang YP; Jin GW; Fu Q; Xiao YS
    J Chromatogr A; 2009 Mar; 1216(11):2033-44. PubMed ID: 18656880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in the determination of urinary cancer biomarkers by capillary electrophoresis.
    Ma Y; Liu G; Du M; Stayton I
    Electrophoresis; 2004 Jun; 25(10-11):1473-84. PubMed ID: 15188229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiles of cancer cells.
    Griffin JL; Shockcor JP
    Nat Rev Cancer; 2004 Jul; 4(7):551-61. PubMed ID: 15229480
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary modified nucleosides as tumor markers.
    Dudley E; Lemiere F; Van Dongen W; Esmans E; El-Sharkawi AM; Games DE; Brenton AG; Newton RP
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):987-9. PubMed ID: 14565327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of urinary nucleosides. V. Identification of urinary pyrimidine nucleosides by liquid chromatography/electrospray mass spectrometry.
    Bond A; Dudley E; Lemière F; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2006; 20(2):137-50. PubMed ID: 16331740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global proteomics and metabolomics in cancer biomarker discovery.
    Issaq HJ; Fox SD; Chan KC; Veenstra TD
    J Sep Sci; 2011 Dec; 34(24):3484-92. PubMed ID: 22102289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic approach for determination of urinary nucleosides as potential tumor markers using electromigration techniques.
    Markuszewski MJ; Struck W; Waszczuk-Jankowska M; Kaliszan R
    Electrophoresis; 2010 Jul; 31(14):2300-10. PubMed ID: 20564268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-pot characterization of cancer cells by the analysis of mucin-type glycans and glycosaminoglycans.
    Yamada K; Mitsui Y; Kakoi N; Kinoshita M; Hayakawa T; Kakehi K
    Anal Biochem; 2012 Feb; 421(2):595-606. PubMed ID: 22212498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of candidate prostate cancer metabolite biomarkers in urine using dispersive derivatization liquid-liquid microextraction followed by gas and liquid chromatography-mass spectrometry.
    Shamsipur M; Naseri MT; Babri M
    J Pharm Biomed Anal; 2013; 81-82():65-75. PubMed ID: 23624158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioanalysis of drugs by liquid-phase microextraction coupled to separation techniques.
    Pedersen-Bjergaard S; Rasmussen KE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(1):3-12. PubMed ID: 15680784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics as a tool for detection of nuclear matrix proteins and new biomarkers for screening of early tumors stage.
    Oehr P
    Anticancer Res; 2003; 23(2A):805-12. PubMed ID: 12820304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.